ReShape Lifesciences Inc. (RSLS) Tops Q1 EPS by 1898c

ReShape Lifesciences Inc. (NASDAQ: RSLS) reported Q1 EPS of $18.98. Revenue for the quarter came in at $1.1 million.

For earnings history and earnings-related data on ReShape Lifesciences Inc. (RSLS) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Cytek faces $56M damages award in Beckman Coulter patent case
• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics